- ￥1338 - 9188
- abinScience
- 中国
- HM006013
- 2026年10月13日
- FCM, IHC
- Mouse
- Human
企业认证
相关产品推荐更多 >
Anti-SARS-CoV-2 S Protein Nanobody (SAA0893), 抗SARS-CoV-2 S Protein纳米抗体 (SAA0893)
￥1338
Anti-POSTN Polyclonal Antibody, 抗POSTN多克隆抗体
￥1008
Anti-Human GFM1 Polyclonal Antibody, 抗人GFM1多克隆抗体
￥1008
Anti-Human WAPL Polyclonal Antibody, 抗人WAPL Polyclonal抗体
￥1008Anti-CD179b/IGLL1 Polyclonal Antibody, 抗CD179b/IGLL1多克隆抗体
￥1008
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
AI 赋能培养基定制开发：CHO 培养基是如何实现产量提升Cytoscape 教程来了！快速实现顶刊同款通路网络图五大应用案例：Mustang Q 膜层析应用全解析1 个小工具，一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 亚型：
IgG1, kappa
- 形态：
Liquid
- 保存条件：
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
- 克隆性：
Monoclonal
- 适应物种：
Human
- 保质期：
1年
- 目录编号：
HM006013
- 库存：
现货
- 供应商：
普健生物（武汉）科技有限公司
- 宿主：
Mouse
- 应用范围：
FCM, IHC
- 靶点：
HLA-DR
- 抗体英文名：
Anti-Hhuman HLA-DR/DP/DQ Recombinant Antibody (F3.3)
- 抗体名：
抗Hhuman HLA-DR/DP/DQ 重组抗体 (F3.3)
- 规格：
50ug/100ug/1mg
| 规格： | 50ug | 产品价格： | ￥1338.0 |
|---|---|---|---|
| 规格： | 100ug | 产品价格： | ￥2288.0 |
| 规格： | 1mg | 产品价格： | ￥9188.0 |
| 产品名称 | Anti-Hhuman HLA-DR/DP/DQ Recombinant Antibody (F3.3) |
|---|---|
| 货号 | HM006013 |
| 宿主 | Mouse |
| 种属反应性 | Human |
| 免疫原 | \ |
| 形态 | Liquid |
| 纯度 | >95% as determined by SDS-PAGE. |
| 克隆性 | Monoclonal |
| 亚型 | IgG1, kappa |
| 应用 | FCM, IHC |
| 靶点 | HLA-DR |
| 标记物 | \ |
abinScience, founded in 2023 in Strasbourg, France, is committed to developing and producing high-quality life science reagents. Rooted in one of Europe’s leading hubs for scientific innovation, abinScience empowers global research through reliable, efficient experimental solutions. Guided by the vision of “Empowering Bioscience Discovery,” we support scientists worldwide in advancing the frontiers of bioscience.
Technology and Innovation
Relying on the global leading position in antibody and protein research and more than 20 years of industry experience of its parent company ProteoGenix since 2003, abinScience has inherited advanced technologies and high-quality standards. In particular, the XtenCHO™ system developed by ProteoGenix, which has two modes of transient expression and stable expression, has been widely recognized as a core technology to improve the efficiency of protein production, providing a solid foundation for abinScience’s product line.
Product categories and application fields.
Main products.
10000+ high-activity proteins.
15000+ antibody series products:
Classic monoclonal antibody.
Monoclonal antibody
Internal control antibody, labeled antibody.
High-quality phosphorylation antibodies.
Highly specific nanobodies and small molecule antibodies.
Functional antibodies in vivo.
Low-background flow cytometry antibodies.
DNA/RNA antibodies and PEG antibodies.
1000+ reagent kit series products.
Large-scale packaging customization services: We offer personalized antibody design, protein production, molecular optimization, and experimental development services.
Application field
Infectious disease research: including viruses, superbugs, parasites, etc.
Neuroscience research: Supporting research on neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease.
Immunology research: Covers the research needs of immune activation, inhibition, and allergies and abnormal reactions.
Oncology research: Supporting the development of tumor biology and anti-tumor drugs.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验和蛋白质及肽结合。六、单一抗体片段它和轻链可变区相互作用的粘连的碎片影响了他们的溶解度和稳定性。它和抗原的亲和力较低而且和不相干的抗原有交叉反应的趋势。七、构建多价体Fv抗体为了增加单价体scFv的亲和性，可以强制缩合肽段使它们形成多聚体。八、产生式系统细菌，酵母菌，植物，昆虫细胞和哺乳动物细胞的抗体和抗体片段的产物都有它的表达系统。1、细菌不能装配所有糖基化的抗体，但是可以装配抗体片段的产物。2、酵母菌可以表达完整的抗体，但含有高的甘露糖和多分支的寡糖，而且在效应器功能方面有缺陷。3、携带杆状
国自然/高分文章利器！CRISPR文库筛选保姆级指南：从Cas9递送到表型选择一文打通！
-1 2、靶向E2F8通过破坏RRM2驱动的DNA修复增敏吉西他滨耐药的胆囊癌对PARP抑制剂的疗效 发表期刊：Journal of Experimental & Clinical Cancer Research 研究机构：复旦大学附属中山医院 研究人员在吉西他滨耐药的NOZ-R胆囊癌细胞中进行了全基因组CRISPR ko筛选（GeCKO v2文库）。敲除转录因子E2F8可显著增强耐药细胞对PARP抑制剂奥拉帕尼的敏感性。机制上，E2F8通过转录上调RRM
TM4SF1：从抗血管新生到免疫逃逸调控，这个四次跨膜蛋白靶点还有多少惊喜？
跨膜4 L6家族成员1（TM4SF1）是四次跨膜蛋白L6超家族成员，在正常组织中低表达，但在胰腺癌、肝癌、卵巢癌、膀胱癌等多种上皮性恶性肿瘤中异常高表达，参与肿瘤细胞增殖、迁移、侵袭和血管生成。近年来，TM4SF1研究已从传统血管新生靶点拓展至免疫微环境调控和铁死亡等前沿领域。2025年《Clinical and Molecular Hepatology》研究揭示TM4SF1通过AKT通路调控肝细胞癌（HCC）细胞衰老和免疫逃逸，高表达TM4SF1与抗PD-1治疗耐药相关，靶向TM
技术资料暂无技术资料 索取技术资料
